Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma

View Full Size 

Download

• Full Size JPEG, 1301x380, 105.2 KB
• Small JPEG, 480x140, 34.0 KB
• Preview JPEG, 144x42, 7.3 KB
• Thumbnail JPEG, 120x35, 6.1 KB